Stock Market & Financial News
Brokers Suggest Investing in QuickLogic (QUIK): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
QUIK +2.64% Is Emcor Group (EME) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
EME +1.93% Wall Street Analysts See Quanta Services (PWR) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
PWR +3.13% Is Kroger (KR) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
KR +1.47% 
Brokers Suggest Investing in AppFolio (APPF): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
APPF +1.86% 
Brokers Suggest Investing in Monday.com (MNDY): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
MNDY +2.36% 
Is Archer Aviation (ACHR) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
ACHR +1.21% 
Is Newmont (NEM) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
NEM -0.58% 
Redwire Climbs 14.3% in Six Months: Is the Stock Still a Buy?
RDW expands its space and defense portfolio as backlog grows, but continued losses and contract execution risks cloud its outlook.
RDW +1.25% 
3 Insurers to Add to Portfolio as AI Transforms Insurance Operations
Travelers, Kinsale Capital and Allstate are using AI, data and technology to improve insurance efficiency, underwriting and growth.
ALL +1.15% 
Credo: The Market Is In Disbelief, But You Shouldn't Be Fooled
Credo Technology stays on the buy list despite a stunning post-earnings de-rating and market skepticism around its optical revenue outlook. CRDO stock's valuation has compressed to 22.5x earnings, with management guiding for >85% growth this fiscal year and no imminent disruption between AEC and optical businesses. Market concerns center on hyperscaler revenue concentration (>60%), potential CapEx slowdown post-FY2028, and whether $600M optical revenue guidance is robust enough.
CRDO +7.9% 
Blue Owl stock may short squeeze as golden cross emerges amid turnaround
Blue Owl stock has staged a strong comeback in recent months, climbing from a low of $7.60 in April to around $11.85 currently. The rally could have further room to run after the stock formed a golden cross and a bullish flag pattern, while fading jitters across the AI sector could provide an additional tailwind.
OWL -1.54% 
Zcash Price Prediction: Confirmed Bullish Pattern Suggests $2,500 Target for ZEC
Zcash (ZEC) is targeting a long-term milestone of $2,500 following a confirmed ascending triangle breakout. Meanwhile, its short-term rally is backed by a historically high shielded supply ratio and heavy short liquidations.
Satoshi-Era Holder Moves 40 BTC Amid New York Property Case
Galaxy Research's official X account said on September 4 that a Bitcoin address dormant since November 5, 2011 moved 40 BTC, worth about $3.09 million, in block 965330. The transaction reactivated a Satoshi-era wallet after nearly 15 years of inactivity. 🌚 Awakened — dormant 14+ years40.00 BTC ($3.09M) untouched since first received 2011-11-05 (14.
Gold, Silver, DXY Outlook: Key Scenarios to Watch
Razan Hilal, StoneX Media Market Analyst, walks through the gold, silver, and U.S. dollar index charts and sets out what confirms the metals move and what breaks it.
Bitcoin Price Plunges From $82K as $78,000 Becomes the Line
Bitcoin's price was caught between short-term selling pressure and a still-rising daily trend Friday, Sept. 4, after a surge to $82,281 gave way to a retreat into the $79,000 area.
Monero liquidity after exchange delistings: How traders compare XMR swap routes
Monero's delisting from exchanges complicates trading, leading to varied liquidity and pricing, necessitating careful route comparison by traders. Monero liquidity after exchange delistings: How traders compare XMR swap routes.
Nextech3D.ai first quarter revenue doubles as event tech scales - ICYMI
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) earlier this week highlighted strong first-quarter growth as CEO Evan Gappelberg said the company was moving beyond its transformation phase and focusing on scaling its AI-powered event technology platform. Gappelberg told Proactive that Q1 revenue grew about 100% year over year, effectively doubling the business, while gross profit increased 79%.
NEXCF -9.09% 
Zscaler shares fall despite earnings beat as free cash flow slides
Zscaler Inc. (NASDAQ:ZS) reported fiscal fourth-quarter revenue and adjusted profit that topped Wall Street estimates on Friday, but a sharp decline in free cash flow sent shares of the cybersecurity company down 3.5%. Free cash flow came in at $60.8 million, missing estimates of $66.9 million and falling 65% from a year earlier, even as the company posted revenue of $898.2 million for the quarter, above analyst estimates of $877 million and up 25% from a year earlier.
ZS -0.32% 
3 Pipeline Stocks Paying Huge Dividends Without Stretching the Payout
High midstream yields look tempting until a payout cut wipes out a year of income, so the real question is not the yield itself but whether the cash flow behind it can actually survive a rough quarter.
EPD +0.17% 
Nvidia has built a $99 billion equity portfolio from almost scratch in 2 years
Nvidia has amassed $99 billion in equity investments by backing its tech peers. That's a 14-fold increase from last summer when it had a roughly $7 billion equity portfolio.
NVDA +1.09% 
Jackson Financial: A Buyback Machine With An Attractive Valuation - Strong Buy
Jackson Financial (JXN) is misunderstood by the market, trading at highly attractive valuation metrics due to perceived earnings volatility. JXN is leveraging cash from its variable-annuity franchise to build a more profitable spread-based annuity business while returning significant capital to shareholders. Q2 2026 results highlight robust expansion: retail annuity sales rose 34%, RILA sales 69%, fixed and FIA sales 73%, with adjusted EPS up 50%.
JXN +0.12% 
Federal Regulators Open Investigation After Tesla Launches Car With No Steering Wheel
On Thursday evening, at ACL Live in downtown Austin, Tesla (NASDAQ:TSLA | TSLA Price Prediction) held an invitation-only launch event for the Cybercab, a passenger vehicle with no steering wheel, no pedals, and no side mirrors.
TSLA -0.2% 
Shell Partners With BP to Expand Deepwater Footprint in Brazil & GoA
SHEL buys stakes in BP-operated deepwater prospects in Brazil and the Gulf of America, expanding exposure to potentially significant discoveries.
SHEL +0.59% 
IONS Secures FDA Nod for Rare Brain Disorder Drug Zanvastro
Ionis' FDA approval of Zanvastro marks the first disease-modifying treatment for Alexander disease and adds a priority review voucher.
IONS -1.46% 
Ciena Outlines Strong 2027 Outlook: What's Fueling the Momentum?
CIEN's AI-driven optical demand, record backlog and supply agreements underpin strong growth through fiscal 2027.
CIEN +7.77% 
Vertiv's UIG Deal Targets the Next Big Constraint in AI Data Centers
Vertiv Holdings NYSE: VRT just made its clearest statement yet about where the next phase of AI infrastructure spending is headed. On Sept. 2, the company announced it will acquire UtilityInnovation Group (UIG), a microgrid and behind-the-meter power specialist.
VRT +1.99% 
Avalo Therapeutics: Phase 2 Validation Has Created An IL-1β Franchise
Avalo Therapeutics (AVTX) is now a well-funded, registrational-stage biotech with validated Phase II data for abdakibart in hidradenitis suppurativa (HS). Abdakibart demonstrated statistically significant HiSCR75 response rates and clean safety, with monthly dosing and efficacy across both biologic-experienced and naive patients. AVTX's $472M cash position secures operations into 2029, reducing near-term dilution risk and enhancing negotiating leverage for Phase 3 and beyond.
FRG 0% 
DocuSign Stock Reverses Early Gains Despite Q2 Beat
Shares of DocuSign (NASDAQ:DOCU) are down 1% to trade at $65.27, pulling back from earlier gains despite the company posting a top- and bottom-line beat for its second-quarter and a raised full-year outlook.
DOCU +3.86% 
Is Palantir's AI Growth Worth the Premium Valuation of its Stock?
PLTR pairs 93% revenue growth with a 62% adjusted operating margin, but its premium valuation leaves little room for disappointment.
PLTR +1.6% 
